Product Information
ARIPIPRAZOLE 30 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1646 per EA under NDC 29300018013. Its NADAC has been published 196 times since Jun 22, 2022.
FDA first approved this application on Dec 1, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300018013
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203025FDA Approved
12/1/2021
TE Code
AB
On Market Since
2/21/2022
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 196 times since Jun 22, 2022, and over the history we have for it it has declined 31.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1646 per EA |
|---|---|
| All-time high | $0.2986 (Sep 13, 2023) |
| All-time low | $0.1365 (Nov 20, 2024) |
| 52-week high | $0.1764 |
| 52-week low | $0.1567 |
| Median price | $0.1834 |
| Average price | $0.2040 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 196 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
The matcher finds 13 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1646 per EA (NDC 29300018013), effective Aug 19, 2026.
How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 31.5%. It has been tracked across 196 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?
Since Jun 22, 2022, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.1365 (Nov 20, 2024) to a high of $0.2986 (Sep 13, 2023), with a median of $0.1834 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?
13 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 30 MG TABLET?
ARIPIPRAZOLE 30 MG TABLET (NDC 29300018013) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.